Resorttrust: Financial results Presentation For 9-month Period Ended December 31, 2024
Resorttrust: Notice Concerning Revision of Earnings and Dividend Forecast
Resorttrust: CONSOLIDATED FINANCIAL SUMMARY 3Q FY 2024 (from April 1, 2024 to December 31, 2024)
Resorttrust: Notice regarding personnel changes
Resorttrust: Notice Concerning Stock Split and Associated Partial Amendment of Articles of Incorporation and Partial Change to Shareholder Benefit Plan
Resorttrust: Notice regarding personnel changes
Resorttrust: Corporate Governance Report
Resorttrust: Notice regarding personnel changes
Resorttrust: CICS Co., Ltd. has completed a 90-day observation period for the main evaluation of the domestic phase 2 clinical trial of BNCT (boron neutron capture therapy) targeting angiosarcoma
Resorttrust: Notice regarding personnel changes in our group
Resorttrust: Financial results Presentation For 6-month Period Ended September 30, 2024
Resorttrust: CONSOLIDATED FINANCIAL SUMMARY 2Q FY 2024 (from April, 2024 to September, 2024)
Resorttrust: Notice regarding personnel changes
Resorttrust: Joint study by Resort Trust Group and Mitsubishi Corporation in the medical tourism field
Resorttrust: Participate in the “MATSURI” business-collaboration project utilizing algae to build a sustainable society
Resorttrust: Notice of opening of the fully membership-based resort hotel “Sanctuary Court Biwako Venetian Modern Resort” on 10/29 (Tue)
Resorttrust: Notice of commencement of medical examinations for membership-based general medical clubs “Grand Hi-Medic Club” and “Hi-Medic Midtown East Course”
Resorttrust: Murata Manufacturing and Resort Trust begin a demonstration experiment to analyze health conditions using smart rings for resort hotel guests
Resorttrust: Signed an agreement with CICS Co., Ltd. (a consolidated subsidiary of Resort Trust), National Cancer Center, Sumitomo Heavy Industries, and Stellar Pharma for clinical trials of BNCT
Resorttrust: Notice regarding the transfer of home-visit nursing station business